In the past year Bio Nova has experienced very rapid growth in many existing markets. The growth and expansion into new markets looks likely to continue in 2008.

Clinical studies regarding Omniflow’s performance both in peripheral revascularisation and AV access have been initiated by independent investigators.

Craig Newton has joined Bio Nova as Marketing Manager to facilitate further growth.